VAERS reports by lot

GSK Hepatitis A lot KM72C: VAERS reports

72 VAERS reports list lot KM72C as a GSK Hepatitis A vaccine, received between 2020-11-23 and 2023-05-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
72
Reports
0%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological960%
Allergic / Anaphylactic213%
Cardiac / Cardiovascular17%
Musculoskeletal17%
Dermatological (non-injection-site)17%
Psychiatric / Neuropsychiatric17%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan9
Washington5
Virginia4
Florida4
Missouri3
Massachusetts3
Pennsylvania3
New York3
Iowa3
Texas3
Colorado3
California3

Reports by month received

2020-112
2021-031
2021-074
2021-083
2021-093
2021-112
2021-121
2022-012
2022-025
2022-032
2022-041
2022-054
2022-064
2022-0723
2022-087
2022-092
2022-105
2023-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.